GB201808477D0 - Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense micorstruture
- Google Patents
Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense micorstruture
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808477.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Algipharma AS
Original Assignee
Algipharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algipharma ASfiledCriticalAlgipharma AS
Priority to GBGB1808477.2ApriorityCriticalpatent/GB201808477D0/en
Publication of GB201808477D0publicationCriticalpatent/GB201808477D0/en
GBGB1808477.2A2018-05-232018-05-23Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense micorstruture
CeasedGB201808477D0
(en)
New standards and medical devices for the preparation of platelet-rich plasma (prp) or concentrated bone marrow (bmc) alone or in combination with hyaluronic acid